批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/12/10 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CHLORPROMAZINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:25MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
080365 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
DR REDDYS |
083329 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
211816 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
No |
No |
AP |
2020/07/07
|
EUGIA PHARMA |
217275 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
No |
No |
AP |
2024/03/13
|
ZYDUS PHARMS |
218229 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
No |
No |
AP |
2024/09/24
|
DEVA HLDING |
216911 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
No |
No |
AP |
2024/10/04
|
GLAND PHARMA LTD |
218272 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
No |
No |
AP |
2024/11/18
|
ASPIRO |
216724 |
001 |
ANDA |
CHLORPROMAZINE HYDROCHLORIDE |
CHLORPROMAZINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
25MG/ML |
Prescription |
No |
No |
AP |
2024/12/10
|
THINQ PHARM-CRO PVT |